Cost-effectiveness of acromegaly treatments: a systematic review.
Letícia P LeonartHelena Hiemisch Lobo BorbaVinicius Lins FerreiraBruno Salgado RiverosRoberto PontaroloPublished in: Pituitary (2018)
Cost-effectiveness studies on acromegaly have been performed in several scenarios, evaluating different phases of treatment. However, the studies present limitations and, overall, were considered of moderate quality. Further economic models should be developed following health economics guidelines recommendations, and must improve transparency.